In a hot line session on Sunday 30th August 2020 at the ESC Congress 2020-The Digital Experience , Dr Jasper Tromp MD, from the National

In a special session at the ESC Congress 2020 – the Digital Experience on latest Hypertension and Heart failure Trials, distinguished speaker Dr Milton Packer

This poster was presented at the ESC Congress 2020- The Digital Experience by Principal Investigator, Professor Roberto Ferrari from the University of Ferrara, Italy on

This poster was presented at the ESC Congress 2020- The Digital Experience by Coordinating Investigator, Dr Jorn Brouwer from the St. Antonius Hospital, Nieuwegein, the

This poster was presented at the ESC Congress 2020- The Digital Experience by Dr Yannick Kaiser from UMC – Location Academic Medical Center, Amsterdam, on

This poster was presented by Dr Paul Welsh from the University of Glasgow, BHF Glasgow Cardiovascular Research Centre – Glasgow – United Kingdom of Great

The recently updated ESC guidelines on the management of dyslipidaemias recommend a more intense LDL-cholesterol (LDL-C) reduction. For patients with atherosclerotic cardiovascular disease (ASCVD) the

The PARALLAX trial was presented in a Hot Line Session on Sunday 30th August 2020 at ESC Congress 2020- The Digital Experience. Sacubitril/valsartan reduces NT-proBNP,

The DAPA-CKD trial presented in a Hot Line Session on Sunday 30th August 2020 at ESC Congress 2020- The Digital Experience. Large cardiovascular outcome trials

Professor Gerhard Hindricks from the Heart Centre Leipzig, Germany) and Professor Tatjana Potpara from the Clinical Centre of Serbia, Belgrade). Presented the 2020 ESC guidelines